Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$973,230
+$851,279 QoQ
Shares Held
1,049
+528.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#251
of 504 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Accent Capital Management, LLC holds $1,172,462 across 18 Biotechnology names. ARGX ranks #1 (83.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
1,049 | $973,230 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
351 | $40,249 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
748 | $18,146 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
138 | $16,916 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
50 | $16,739 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
31 | $16,645 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
107 | $11,880 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
214 | $11,757 |
All Filings in ARGX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $973,230 | 1,049 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $121,951 | 167 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $83,254 | 99 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $73,018 | 99 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $54,570 | 99 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $46,165 | 78 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $47,970 | 78 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $42,282 | 78 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $29,242 | 68 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $20,867 | 53 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,162 | 53 | Shares | Sole | 2024-03-19 | |
| No filing history on record for this holder in this stock. | ||||||